Cytosorbents (CTSO) EBT Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | Cytosorbents | 23.26 Mn | 18.85 Mn | 7.05 Mn | 760.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19,372.00 |
| Mar 31, 2026 | -10,761.00 |
| Dec 31, 2025 | -8,647.00 |
| Sep 30, 2025 | -551.00 |
| Jun 30, 2025 | -21,359.00 |
| Mar 31, 2025 | 5,079.00 |
| Dec 31, 2024 | 10,710.00 |
| Sep 30, 2024 | 7,215.00 |
| Jun 30, 2024 | 2,149.00 |
| Mar 31, 2024 | 976.00 |
| Dec 31, 2023 | -6,037.00 |
| Sep 30, 2023 | 4,613.00 |
| Jun 30, 2023 | 5,799.00 |
| Mar 31, 2023 | 2,567.00 |
| Dec 31, 2022 | 7,335.00 |
| Sep 30, 2022 | -8,478.00 |
| Jun 30, 2022 | -8,916.00 |
| Mar 31, 2022 | -6,384.00 |
| Dec 31, 2021 | -7,805.00 |
| Sep 30, 2021 | -5,767.00 |